Immediate Impact
9 by Nobel laureates 3 from Science/Nature 68 standout
Citing Papers
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
2022 Standout
Works of Daniel Gandía being referenced
Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
1995
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Gandía | 426 | 492 | 96 | 128 | 12 | 659 | |
| Laurence Goethals | 175 | 232 | 123 | 240 | 23 | 809 | |
| Kristina Lamberg | 191 | 402 | 59 | 412 | 20 | 762 | |
| Corbett Th | 269 | 377 | 113 | 142 | 8 | 649 | |
| Trader Mw | 292 | 401 | 104 | 151 | 16 | 716 | |
| A.E.C. Korst | 287 | 263 | 65 | 157 | 20 | 673 | |
| Jun Zheng | 327 | 194 | 80 | 109 | 15 | 742 | |
| Ger‐Jan Sanderink | 185 | 344 | 91 | 90 | 12 | 703 | |
| A Krikorian | 193 | 595 | 39 | 185 | 14 | 744 | |
| Yaowei Zhang | 259 | 238 | 96 | 246 | 26 | 665 | |
| Tarja Ruotsalainen | 458 | 346 | 58 | 178 | 11 | 725 |
All Works
Loading papers...